Monday, February 8, 2016

Research discovers neuroprotective protein in blood is biomarker of Alzheimer's disease

Medical professionals have to conduct a long series of tests to assess a patient’s memory impairment and cognitive skills, functional abilities, and behavioral changes to accurately diagnose Alzheimer’s disease. They also have to execute costly brain imagining scans and even, sometimes, invasive cerebral spinal fluid tests to rule out other diseases. The process is laborious at best—and subjective at worst.

from Dementia Big http://ift.tt/1olnoIH via alcoholic dementia


http://ift.tt/1XeMQeU

No comments:

Post a Comment